161 related articles for article (PubMed ID: 27207056)
1. Development of a novel CsA-PLGA drug delivery system based on a glaucoma drainage device for the prevention of postoperative fibrosis.
Dai Z; Yu X; Hong J; Liu X; Sun J; Sun X
Mater Sci Eng C Mater Biol Appl; 2016 Sep; 66():206-214. PubMed ID: 27207056
[TBL] [Abstract][Full Text] [Related]
2. Grooved Glaucoma Drainage Devices That Continuously Deliver Cyclosporine A Decrease Postsurgical Scar Formation in Rabbit Eyes.
Dai Z; Yu X; Sun J; Sun X
Invest Ophthalmol Vis Sci; 2017 Mar; 58(3):1692-1701. PubMed ID: 28319643
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic and toxicity study of an intraocular cyclosporine DDS in the anterior segment of rabbit eyes.
Theng JT; Ti SE; Zhou L; Lam KW; Chee SP; Tan D
Invest Ophthalmol Vis Sci; 2003 Nov; 44(11):4895-9. PubMed ID: 14578414
[TBL] [Abstract][Full Text] [Related]
4. A novel antiproliferative drug coating for glaucoma drainage devices.
Ponnusamy T; Yu H; John VT; Ayyala RS; Blake DA
J Glaucoma; 2014; 23(8):526-34. PubMed ID: 23632409
[TBL] [Abstract][Full Text] [Related]
5. [Drug release and biocompatibility of cyclosporine A drug delivery system implanting into the anterior chamber].
Liu ZS; Xie LX; Shi WY; Li SW; Cai Q; Bei JZ; Wang SG
Zhonghua Yan Ke Za Zhi; 2004 Feb; 40(2):108-12. PubMed ID: 15059564
[TBL] [Abstract][Full Text] [Related]
6. New approach to treating spinal cord injury using PEG-TAT-modified, cyclosporine-A-loaded PLGA/polymeric liposomes.
Gao SJ; Liu Y; Wang HJ; Ban DX; Cheng SZ; Ning GZ; Wang LL; Chang J; Feng SQ
J Drug Target; 2017 Jan; 25(1):75-82. PubMed ID: 27250819
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic and toxicological evaluations of cyclosporine a microspheres as a treatment vehicle for uveitis in rabbits.
He Y; Wang JC; Liu YL; Ma ZZ; Zhu XA; Zhang Q
J Ocul Pharmacol Ther; 2006 Apr; 22(2):121-31. PubMed ID: 16722798
[TBL] [Abstract][Full Text] [Related]
8. Retinal ganglion cells survival in a glaucoma model by GDNF/Vit E PLGA microspheres prepared according to a novel microencapsulation procedure.
Checa-Casalengua P; Jiang C; Bravo-Osuna I; Tucker BA; Molina-MartÃnez IT; Young MJ; Herrero-Vanrell R
J Control Release; 2011 Nov; 156(1):92-100. PubMed ID: 21704662
[TBL] [Abstract][Full Text] [Related]
9. Controlled release of ethacrynic acid from poly(lactide-co-glycolide) films for glaucoma treatment.
Wang Y; Challa P; Epstein DL; Yuan F
Biomaterials; 2004 Aug; 25(18):4279-85. PubMed ID: 15046918
[TBL] [Abstract][Full Text] [Related]
10. A biodegradable drug delivery system for the treatment of postoperative inflammation.
Eperon S; Bossy-Nobs L; Petropoulos IK; Gurny R; Guex-Crosier Y
Int J Pharm; 2008 Mar; 352(1-2):240-7. PubMed ID: 18093765
[TBL] [Abstract][Full Text] [Related]
11. In vivo release and retinal toxicity of cyclosporine-loaded intravitreal device.
de Almeida FP; Saliba JB; Ribeiro JA; Siqueira RC; Fialho SL; Silva-Cunha A; Jorge R; Messias A
Doc Ophthalmol; 2015 Dec; 131(3):207-14. PubMed ID: 26576763
[TBL] [Abstract][Full Text] [Related]
12. A new drug delivery system inhibits uveitis in an animal model after cataract surgery.
Eperon S; Rodriguez-Aller M; Balaskas K; Gurny R; Guex-Crosier Y
Int J Pharm; 2013 Feb; 443(1-2):254-61. PubMed ID: 23291445
[TBL] [Abstract][Full Text] [Related]
13. Glaucoma Drainage Device Coated with Mitomycin C Loaded Opal Shale Microparticles to Inhibit Bleb Fibrosis.
Dong A; Han L; Shao Z; Fan P; Zhou X; Yuan H
ACS Appl Mater Interfaces; 2019 Mar; 11(10):10244-10253. PubMed ID: 30689341
[TBL] [Abstract][Full Text] [Related]
14. Nanoparticle-Mediated Targeting of Cyclosporine A Enhances Cardioprotection Against Ischemia-Reperfusion Injury Through Inhibition of Mitochondrial Permeability Transition Pore Opening.
Ikeda G; Matoba T; Nakano Y; Nagaoka K; Ishikita A; Nakano K; Funamoto D; Sunagawa K; Egashira K
Sci Rep; 2016 Feb; 6():20467. PubMed ID: 26861678
[TBL] [Abstract][Full Text] [Related]
15. [Experimental study of low molecular weight heparin drug delivery system for prevention of posterior capsular opacification in rabbit eyes].
Dai YH; Xie LX; Wu XG; Huang YS; Gong HQ; Yin HM
Zhonghua Yan Ke Za Zhi; 2009 Nov; 45(11):1033-8. PubMed ID: 20137424
[TBL] [Abstract][Full Text] [Related]
16. The PLGA implant as an antimitotic delivery system after experimental trabeculectomy.
RodrÃguez-Agirretxe I; Vega SC; Rezola R; Vecino E; Mendicute J; Suarez-Cortes T; Acera A
Invest Ophthalmol Vis Sci; 2013 Aug; 54(8):5227-35. PubMed ID: 23800769
[TBL] [Abstract][Full Text] [Related]
17. Cyclosporine a drug-delivery system for high-risk penetrating keratoplasty: Stabilizing the intraocular immune microenvironment.
Zhang T; Li Z; Liu T; Li S; Gao H; Wei C; Shi W
PLoS One; 2018; 13(5):e0196571. PubMed ID: 29734357
[TBL] [Abstract][Full Text] [Related]
18. Sustained subconjunctival delivery of cyclosporine A using thermogelling polymers for glaucoma filtration surgery.
Sun J; Liu X; Lei Y; Tang M; Dai Z; Yang X; Yu X; Yu L; Sun X; Ding J
J Mater Chem B; 2017 Aug; 5(31):6400-6411. PubMed ID: 32264457
[TBL] [Abstract][Full Text] [Related]
19. Cyclosporine-loaded microspheres for treatment of uveitis: in vitro characterization and in vivo pharmacokinetic study.
He Y; Liu Y; Liu Y; Wang J; Zhang X; Lu W; Ma Z; Zhu X; Zhang Q
Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3983-8. PubMed ID: 16936114
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Tenon's fibroblast proliferation and enhancement of filtration surgery in rabbits with cytosine arabinoside.
Al-Aswad LA; Huang M; Netland PA
J Ocul Pharmacol Ther; 1999 Feb; 15(1):41-9. PubMed ID: 10048346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
